Stay updated on Elsubrutinib & Upadacitinib in SLE Clinical Trial
Sign up to get notified when there's something new on the Elsubrutinib & Upadacitinib in SLE Clinical Trial page.

Latest updates to the Elsubrutinib & Upadacitinib in SLE Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe record history shows a new revision v3.4.3 added, replacing the previous v3.4.2.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedA new revision entry v3.4.2 was added and the previous v3.4.1 entry was removed, reflecting a minor maintenance update to the record history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedA new site revision (v3.4.1) has been added to the history, replacing the previous revision (v3.4.0).SummaryDifference0.1%

- Check48 days agoChange DetectedThe history page adds a Show glossary option and color-coded highlights for additions and deletions. It also updates the revision note to v3.4.0 and removes 'No FEAR Act Data'.SummaryDifference0.6%

- Check62 days agoChange DetectedA new revision label v3.3.4 was added to the history and the older label v3.3.3 was removed.SummaryDifference0.1%

- Check84 days agoChange DetectedThe page history now includes a new entry: Revision: v3.3.3. The HHS Vulnerability Disclosure and the Revision: v3.3.2 entries were removed.SummaryDifference0.1%

Stay in the know with updates to Elsubrutinib & Upadacitinib in SLE Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elsubrutinib & Upadacitinib in SLE Clinical Trial page.